The percentage of CD4+ T cells present in the effusions is significantly correlated with response to chemotherapy, while the percentage of PD-L1+ PDPN+ tumor cells can be translated as a significant prognostic factor for worse outcome. The gene discussed is CD274; the disease is neoplasm.